Mead Johnson Nutrition Now Covered by Oppenheimer (MJN)

Stock analysts at Oppenheimer began coverage on shares of Mead Johnson Nutrition (NYSE:MJN) in a report issued on Wednesday, TheFlyOnTheWall.com reports. The firm set a “market perform” rating on the stock. The analysts noted that the move was a valuation call.

Mead Johnson Nutrition (NYSE:MJN) traded up 0.43% on Wednesday, hitting $73.15. Mead Johnson Nutrition has a 1-year low of $61.27 and a 1-year high of $86.87. The stock’s 50-day moving average is currently $75.43. The company has a market cap of $14.831 billion and a price-to-earnings ratio of 24.43.

Mead Johnson Nutrition (NYSE:MJN) last issued its quarterly earnings data on Thursday, July 25th. The company reported $0.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.83 by $0.01. The company had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.04 billion. During the same quarter in the previous year, the company posted $0.83 earnings per share. The company’s revenue for the quarter was up 4.2% on a year-over-year basis. On average, analysts predict that Mead Johnson Nutrition will post $3.25 earnings per share for the current fiscal year.

A number of other firms have also recently commented on MJN. Analysts at Zacks downgraded shares of Mead Johnson Nutrition from a “neutral” rating to an “underperform” rating in a research note to investors on Tuesday, July 16th. They now have a $71.90 price target on the stock. Separately, analysts at TheStreet reiterated a “buy” rating on shares of Mead Johnson Nutrition in a research note to investors on Thursday, July 11th. Finally, analysts at Morgan Stanley downgraded shares of Mead Johnson Nutrition from an “overweight” rating to an “equal weight” rating in a research note to investors on Friday, July 5th. They now have a $76.00 price target on the stock.

One research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and four have issued a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $79.08.

Mead Johnson Nutrition Company (NYSE:MJN) is a global pediatric nutrition company.